Targeting KIF20A: a new frontier in cancer treatment revealed by multi-omics analysis
To our knowledge, this is the first study to reveal the role of KIF20A in tumorigenesis and development from a pan-cancer multi-omics perspective, providing solid theoretical and experimental evidence for KIF20A as a potential anti-cancer therapeutic target.
Authors
- M. Z. Yang (ORCID: https://orcid.org/0000-0003-0421-0358)
- Chunling Qi
- Guanghao Li (ORCID: https://orcid.org/0000-0001-6955-5571)
- W J Guo
- Jie Zhang
Institutions
- Qingdao University (CN)
- Shandong Tumor Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Taian City Central Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fimmu.2026.1744899
- Primary Topic
- Microtubule and mitosis dynamics
- Type
- article
- Field-Weighted Citation Impact
- 0.00